← Back
$CRNX All transactions

Crinetics Pharmaceuticals, Inc.

M 10b5-1 Plan

$ Value

$84K

Shares

5,000

Price

$17

Filed

Oct 3

Insider

Name

Pizzuti Dana

Title

Chief Med and Dev Officer

CIK

0001948238

Roles

Officer

Transaction Details

Transaction Date

2025-10-01

Code

M

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

71,270

Footnotes

On September 4, 2025, the Reporting Person filed a Form 4 (the "Prior Form 4") which inadvertently reported that, following the transactions reported in the Prior Form 4, the Reporting Person directly owned 96,270 shares of the Issuer's common stock. In fact, the Reporting Person directly owned 66,270 shares of the Issuer's common stock following the transactions reported in the Prior Form 4. | The sale reported in this Form 4 was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 21, 2025. | The common stock was sold by the Reporting Person in open market transactions on the transaction date, with a volume weighted average sales price of $41.81 per share. The range of sales prices on the transaction date was $41.34 to $42.16 per share. Detailed information on the exact number of shares can be obtained from the Issuer upon request. | The option is exercisable as follows: 25% of the shares subject to the option vested on September 30, 2023, and the remaining number of shares subject to the option vest monthly thereafter in thirty-six equal monthly installments, subject to the Reporting Person's continued employment with the Issuer on each such vesting date.

Filing Info

Accession No.

0001658247-25-000013

Form Type

4

Issuer CIK

0001658247

Pizzuti Dana's History

Date Ticker Type Value
2025-12-01 CRNX M $84K
2025-12-01 CRNX $225K
2025-12-01 CRNX M $0
2025-11-03 CRNX M $84K
2025-11-03 CRNX $209K
2025-11-03 CRNX $4K
2025-11-03 CRNX M $0
2025-10-01 CRNX M $84K
2025-10-01 CRNX $209K
2025-10-01 CRNX M $0

Other Insiders at CRNX (90d)

Insider Bought Sold Last
Knight Jeff E.
Chief Dev. & Operating Officer
$3.4M 2026-04-08